Cardiovascular Systems
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Cardiovascular Systems generated cash of -$24,272,000, which is less than the previous year. Cash used in financing activities reached the amount of -$2,535,000 last year. Net change in cash is therefore -$4,646,000.
Cash Flow
| 2013 | -10.76M | -2.45M | 45.58M |
|---|---|---|---|
| 2014 | -26.83M | -13.41M | 98.95M |
| 2015 | -22.35M | -23.02M | 2.63M |
| 2016 | -23.58M | -3.76M | 4.14M |
| 2017 | 19.58M | -1.77M | 29.46M |
| 2018 | 9.67M | -5.09M | 3.76M |
| 2019 | 10.20M | -54.35M | 2.12M |
| 2020 | -12.76M | -8.66M | 132.66M |
| 2021 | -884K | -112.70M | -800K |
| 2022 | -24.27M | 22.16M | -2.53M |
CSII Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 71.07M | 185.46M | 74.23M | 116.26M | 107.91M | 60.63M | 83.84M | 126.59M | 67.89M | 35.52M |
Operating activities | ||||||||||
Net income | -36.93M | -13.42M | -27.23M | -255K | 1.71M | -1.79M | -56.02M | -32.82M | -35.29M | -24.03M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 5.02M | 4.31M | 4.17M | 3.44M | 3.93M | 4.13M | 3.91M | 2.32M | 1.36M | 973K |
Stock-based compensation expense | 17.84M | 16.23M | 13.61M | 11.26M | 10.30M | 10.35M | 12.97M | 14.71M | 10.92M | 7.44M |
| Deferred income tax benefit | 17.84M | 16.23M | 13.61M | 11.26M | 10.30M | 10.35M | 12.97M | 14.71M | 10.92M | 7.44M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 205K | -14.82M | 9.50M | -4.91M | -2.87M | -5.80M | 7.32M | -10.56M | -6.71M | -1.28M |
Inventories | -2.25M | -4.60M | -9.64M | -1.45M | 292K | 543K | -3.47M | -1.07M | -6.64M | 818K |
Accounts payable | 677K | 2.07M | 576K | 566K | 104K | 1.76M | -970K | 581K | 4.62M | 1.48M |
Cash generated by operating activities | -24.27M | -884K | -12.76M | 10.20M | 9.67M | 19.58M | -23.58M | -22.35M | -26.83M | -10.76M |
Investing activities | ||||||||||
Purchases Of Investments | -124.32M | -213.54M | -39.53M | -50.94M | -2.53M | 0 | -37K | -2.11M | 0 | 0 |
Investments In Property Plant And Equipment | -4.22M | -3.95M | -4.08M | -3.55M | -3.06M | -1.82M | -4.63M | -21.28M | -13.41M | -2.45M |
Acquisitions Net | -1.7M | -3.35M | -5.74M | 890K | -1.11M | 0 | -813K | 0 | 0 | 0 |
Cash generated by investing activities | 22.16M | -112.70M | -8.66M | -54.35M | -5.09M | -1.77M | -3.76M | -23.02M | -13.41M | -2.45M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 134.97M | 0 | 0 | 0 | 0 | 0 | 84.36M | 38.20M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -154K | -92K | 0 | 0 | 0 | 0 | 0 | -9.85M | -4.8M |
Cash used in financing activities | -2.53M | -800K | 132.66M | 2.12M | 3.76M | 29.46M | 4.14M | 2.63M | 98.95M | 45.58M |
Net Change In Cash | -4.64M | -114.39M | 111.22M | -42.02M | 8.34M | 47.27M | -23.20M | -42.75M | 58.69M | 32.36M |
Cash at end of period | 66.42M | 71.07M | 185.46M | 74.23M | 116.26M | 107.91M | 60.63M | 83.84M | 126.59M | 67.89M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |